What I said was that they weren't aligned to timelines, and sometimes not also to intellectual property needs and the need to retain confidentiality about some things that are strategic business advantages. We find sometimes with universities that keeping projects on track in a timely fashion, not having them be interrupted by whatever the academic schedule is, is a bit of a challenge. Sometimes research that is done in industry is deemed to be somehow second-class, for whatever reason, even though I'm biased to think that it's not.
So I think we have a bit of a cultural mindset there, but that universities are coming around to the idea that working with industry sooner rather than later in research forums—we're not talking about pharmaceuticals here, but about research that's closer to manufacturing—is an efficient thing to do and actually a good thing to do.